ArticleEuropean heart journal. Cardiovascular pharmacotherapy2026

Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity score-matched analysis.

Haolan Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.